loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 203696 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ABBVIE ENDOCRINE (2)

filter

01 INJECTABLE, TABLET;INTRAMUSCULAR, ORAL (2)

filter

01 DISCN (2)

filter

01 LUPANETA PACK (2)

filter

01 Yes (2)

URL Supplier Web Content
INJECTABLE, TABLET...
3.75MG/VIAL,N/A;N/...
2012-12-14
203696
LUPANETA PACK
DISCN
Yes
Abbvie Company Banner

ICRI Spring Convention

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
INJECTABLE, TABLET...
11.25MG/VIAL,N/A;N...
2012-12-14
203696
LUPANETA PACK
DISCN
Yes
Abbvie Company Banner

ICRI Spring Convention

Not Confirmed

envelop Contact Supplier

Looking for FDA Orange Book APPLICATION 203696

Looking for FDA Orange Book APPLICATION 203696 2

19

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEUPROLIDE ACETATE; NORETHINDRONE ACETATE, with a corresponding application number 203696.

Regulatory Information DISCN

With a dosage strength 3.75MG/VIAL,N/A;N/A,5MG

Dosage Form Route INJECTABLE, TABLET; INTRAMUSCULAR, ORAL

Reference Listed Drug Yes

Approved since 2012-12-14

18

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LEUPROLIDE ACETATE; NORETHINDRONE ACETATE, with a corresponding application number 203696.

Regulatory Information DISCN

With a dosage strength 11.25MG/VIAL,N/A;N/A,5MG

Dosage Form Route INJECTABLE, TABLET; INTRAMUSCULAR, ORAL

Reference Listed Drug Yes

Approved since 2012-12-14

Post Enquiry
POST ENQUIRY